1887

Journal of Medical Microbiology logo

Volume 60, Issue 2

Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of in irritable bowel syndrome Free

Abstract

Intestinal microbiota may play a role in the pathophysiology of irritable bowel syndrome (IBS). In this case–control study, mucosa-associated small intestinal and faecal microbiota of IBS patients and healthy subjects were analysed using molecular-based methods. Duodenal mucosal brush and faecal samples were collected from 37 IBS patients and 20 healthy subjects. The bacterial 16S rRNA gene was amplified and analysed using PCR denaturing gradient gel electrophoresis (DGGE). Pooled average DGGE profiles of all IBS patients and all healthy subjects from both sampling sites were generated and fingerprints of both groups were compared. The DGGE band fragments which were confined to one group were further characterized by sequence analysis. Quantitative real-time PCR (q-PCR) was used to quantify the disease-associated microbiota. Averaged DGGE profiles of both groups were identical for 78.2 % in the small intestinal samples and for 86.25 % in the faecal samples. Cloning and sequencing of the specific bands isolated from small intestinal and faecal DGGE patterns of IBS patients showed that 45.8 % of the clones belonged to the genus , of which was the predominant species. q-PCR analysis revealed higher levels (<0.001) of in the small intestine of IBS patients (8.3 %±0.950) than in the small intestine of healthy subjects (0.1 %±0.069). was also significantly (<0.001) more abundant (2.34 %±0.31) in faeces of IBS patients than in faeces of healthy subjects (0.003 %±0.0027). This study shows that is detected more frequently and at higher levels in IBS patients than in healthy subjects, suggesting its potential role in the pathophysiology of IBS.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): DGGE, denaturing gradient gel electrophoresis , IBS, irritable bowel syndrome and q-PCR, quantitative real-time PCR
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.022848-0
2011-02-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/2/236.html?itemId=/content/journal/jmm/10.1099/jmm.0.022848-0&mimeType=html&fmt=ahah

References

  1. Adlard P. A., Kirov S. M., Sanderson K., Cox G. E. 1998; Pseudomonas aeruginosa as a cause of infectious diarrhoea. Epidemiol Infect 121:237–241 [CrossRef]
     [Google Scholar]
  2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. 1990; Basic local alignment search tool. J Mol Biol 215:403–410 [CrossRef]
     [Google Scholar]
  3. Balsari A., Ceccarelli A., Dubini F., Fesce E., Poli G. 1982; The fecal microbial population in the irritable bowel syndrome. Microbiologica 5:185–194
     [Google Scholar]
  4. Baron A. D., Hollander H. 1993; Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis 148:992–996 [CrossRef]
     [Google Scholar]
  5. Bleday R., Braidt J., Ruoff K., Shellito P. C., Ackroyd F. W. 1993; Quantitative cultures of the mucosal-associated bacteria in the mechanically prepared colon and rectum. Dis Colon Rectum 36:844–849 [CrossRef]
     [Google Scholar]
  6. Bonten M. J., Bergmans D. C., Speijer H., Stobberingh E. E. 1999; Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am J Respir Crit Care Med 160:1212–1219 [CrossRef]
     [Google Scholar]
  7. Brooks S. P., McAllister M., Sandoz M., Kalmokoff M. L. 2003; Culture-independent phylogenetic analysis of the faecal flora of the rat. Can J Microbiol 49:589–601 [CrossRef]
     [Google Scholar]
  8. Collins S. M., Piche T., Rampal P. 2001; The putative role of inflammation in the irritable bowel syndrome. Gut 49:743–745 [CrossRef]
     [Google Scholar]
  9. Dulon S., Leduc D., Cottrell G. S., D'Alayer J., Hansen K. K., Bunnett N. W., Hollenberg M. D., Pidard D., Chignard M. 2005; Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 32:411–419 [CrossRef]
     [Google Scholar]
  10. Eckburg P. B., Bik E. M., Bernstein C. N., Purdom E., Dethlefsen L., Sargent M., Gill S. R., Nelson K. E., Relman D. A. 2005; Diversity of the human intestinal microbial flora. Science 308:1635–1638 [CrossRef]
     [Google Scholar]
  11. Edlund C., Nord C. E. 2000; Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J Antimicrob Chemother 46 (Suppl. 1):41–48 [CrossRef]
     [Google Scholar]
  12. Fichtenbaum C. J., Woeltje K. F., Powderly W. G. 1994; Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 19:417–422 [CrossRef]
     [Google Scholar]
  13. Flanagan J. L., Brodie E. L., Weng L., Lynch S. V., Garcia O., Brown R., Hugenholtz P., DeSantis T. Z., Andersen G. L. other authors 2007; Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa . J Clin Microbiol 45:1954–1962 [CrossRef]
     [Google Scholar]
  14. Furrie E. 2006; A molecular revolution in the study of intestinal microflora. Gut 55:141–143 [CrossRef]
     [Google Scholar]
  15. George S. E., Walsh D. B., Stead A. G., Claxton L. D. 1989; Effect of ampicillin-induced alterations in murine intestinal microbiota on the survival and competition of environmentally released pseudomonads. Fundam Appl Toxicol 13:670–680 [CrossRef]
     [Google Scholar]
  16. Gorbach S. L., Barza M., Giuliano M., Jacobus N. V. 1988; Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. Eur J Clin Microbiol Infect Dis 7:98–102 [CrossRef]
     [Google Scholar]
  17. Hentges D. J., Stein A. J., Casey S. W., Que J. U. 1985; Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infect Immun 47:118–122
     [Google Scholar]
  18. Hooper L. V., Gordon J. I. 2001; Commensal host-bacterial relationships in the gut. Science 292:1115–1118 [CrossRef]
     [Google Scholar]
  19. Hopkins M. J., Macfarlane G. T. 2002; Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51:448–454
     [Google Scholar]
  20. Kassinen A., Krogius-Kurikka L., Makivuokko H., Rinttila T., Paulin L., Corander J., Malinen E., Apajalahti J., Palva A. 2007; The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133:24–33 [CrossRef]
     [Google Scholar]
  21. Kerckhoffs A. P. M., Samsom M., van der Rest M. E., de Vogel J., Knol J., Ben-Amor K., Akkermans L. M. A. 2009; Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients assessed by molecular analysis. World J Gastroenterol 15:2887–2892 [CrossRef]
     [Google Scholar]
  22. Kessner D. M., Lepper M. H. 1967; Epidemiologic studies on gram-negative bacilli in the hospital and community. Am J Epidemiol 85:45–60
     [Google Scholar]
  23. King T. S., Elia M., Hunter J. O. 1998; Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352:1187–1189 [CrossRef]
     [Google Scholar]
  24. Kühbacher T., Ott S. J., Helwig U., Mimura T., Rizzello F., Kleessen B., Gionchetti P., Blaut M., Campieri M. other authors 2006; Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55:833–841 [CrossRef]
     [Google Scholar]
  25. León-Barúa R., Gilman R. H., Rodríguez C., Bonilla J. J., Yi A., Maúrtua D., Sack R. B. 1993; Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol 88:925–928
     [Google Scholar]
  26. Lepage P., Seksik P., Sutren M., de la Cochetiere M. F., Jian R., Marteau P., Dore J. 2005; Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 11:473–480 [CrossRef]
     [Google Scholar]
  27. Levison M. E. 1973; Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginosa and Enterobacteriaceae . Infect Immun 8:30–35
     [Google Scholar]
  28. Levy J. 2000; The effects of antibiotic use on gastrointestinal function. Am J Gastroenterol 95:S8–S10 [CrossRef]
     [Google Scholar]
  29. Li M., Wang B., Zhang M., Rantalainen M., Wang S., Zhou H., Zhang Y., Shen J., Pang X. other authors 2008; Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105:2117–2122 [CrossRef]
     [Google Scholar]
  30. Liu W., Saint D. A. 2002a; A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302:52–59 [CrossRef]
     [Google Scholar]
  31. Liu W., Saint D. A. 2002b; Validation of a quantitative method for real time PCR kinetics. Biochem Biophys Res Commun 294:347–353 [CrossRef]
     [Google Scholar]
  32. Livermore D. M. 1992; Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa . Antimicrob Agents Chemother 36:2046–2048 [CrossRef]
     [Google Scholar]
  33. Madden J. A., Hunter J. O. 2002; A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 88:S67–S72 [CrossRef]
     [Google Scholar]
  34. Mah T. F., Pitts B., Pellock B., Walker G. C., Stewart P. S., O'Toole G. A. 2003; A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306–310 [CrossRef]
     [Google Scholar]
  35. Mai V., Morris J. G. Jr 2004; Colonic bacterial flora: changing understandings in the molecular age. J Nutr 134:459–464
     [Google Scholar]
  36. Malinen E., Rinttila T., Kajander K., Matto J., Kassinen A., Krogius L., Saarela M., Korpela R., Palva A. 2005; Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100:373–382 [CrossRef]
     [Google Scholar]
  37. Masuda N., Gotoh N., Ishii C., Sakagawa E., Ohya S., Nishino T. 1999; Interplay between chromosomal β -lactamase and the MexAB-OprM efflux system in intrinsic resistance to β -lactams in Pseudomonas aeruginosa . Antimicrob Agents Chemother 43:400–402
     [Google Scholar]
  38. Maxwell P. R., Rink E., Kumar D., Mendall M. A. 2002; Antibiotics increase functional abdominal symptoms. Am J Gastroenterol 97:104–108 [CrossRef]
     [Google Scholar]
  39. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtvedt T., Cresci A., Silvi S., Orpianesi C. other authors 2006; Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027–1033 [CrossRef]
     [Google Scholar]
  40. Muyzer G., Smalla K. 1998; Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie van Leeuwenhoek 73:127–141 [CrossRef]
     [Google Scholar]
  41. Muyzer G., de Waal E. C., Uitterlinden A. G. 1993; Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59:695–700
     [Google Scholar]
  42. Nadkarni M. A., Martin F. E., Jacques N. A., Hunter N. 2002; Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148:257–266
     [Google Scholar]
  43. Niedzielin K., Kordecki H., Birkenfeld B. 2001; A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13:1143–1147 [CrossRef]
     [Google Scholar]
  44. Nobaek S., Johansson M. L., Molin G., Ahrne S., Jeppsson B. 2000; Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95:1231–1238 [CrossRef]
     [Google Scholar]
  45. Oliver A., Canton R., Campo P., Baquero F., Blazquez J. 2000; High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251–1254 [CrossRef]
     [Google Scholar]
  46. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., O'Sullivan G. C., Kiely B., Collins J. K. other authors 2005; Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128:541–551 [CrossRef]
     [Google Scholar]
  47. Parry S. D., Stansfield R., Jelley D., Gregory W., Phillips E., Barton J. R., Welfare M. R. 2003; Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 98:1970–1975
     [Google Scholar]
  48. Pimentel M., Chow E. J., Lin H. C. 2000; Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 95:3503–3506 [CrossRef]
     [Google Scholar]
  49. Pirnay J. P., De Vos D., Duinslaeger L., Reper P., Vandenvelde C., Cornelis P., Vanderkelen A. 2000; Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'real-time' polymerase chain reaction. Crit Care 4:255–261 [CrossRef]
     [Google Scholar]
  50. Posserud I., Stotzer P. O., Bjornsson E. S., Abrahamsson H., Simrén M. 2007; Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56:802–808 [CrossRef]
     [Google Scholar]
  51. Quigley E. M. 2007; Probiotics in irritable bowel syndrome: an immunomodulatory strategy?. J Am Coll Nutr 26:684S–690S [CrossRef]
     [Google Scholar]
  52. Rodríguez L. A., Ruigómez A. 1999; Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 318:565–566 [CrossRef]
     [Google Scholar]
  53. Sanguinetti C. J., Dias N. E., Simpson A. J. 1994; Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17:914–921
     [Google Scholar]
  54. Si J. M., Yu Y. C., Fan Y. J., Chen S. J. 2004; Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10:1802–1805
     [Google Scholar]
  55. Speert D. P., Campbell M. E., Davidson A. G., Wong L. T. 1993; Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis. J Infect Dis 167:226–229 [CrossRef]
     [Google Scholar]
  56. Spiller R. C. 2007; Role of infection in irritable bowel syndrome. J Gastroenterol 42 (Suppl. 17):41–47 [CrossRef]
     [Google Scholar]
  57. Suau A., Bonnet R., Sutren M., Godon J. J., Gibson G. R., Collins M. D., Dore J. 1999; Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807
     [Google Scholar]
  58. Vaughan E. E., Schut F., Heilig H. G., Zoetendal E. G., de Vos W. M., Akkermans A. D. 2000; A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol 1:1–12
     [Google Scholar]
  59. Vergnolle N. 2005; Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 54:867–874 [CrossRef]
     [Google Scholar]
  60. Walters M. C. III, Roe F., Bugnicourt A., Franklin M. J., Stewart P. S. 2003; Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47:317–323 [CrossRef]
     [Google Scholar]
  61. Woodmansey E. J., McMurdo M. E., Macfarlane G. T., Macfarlane S. 2004; Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70:6113–6122 [CrossRef]
     [Google Scholar]
  62. Zhang Z., Schwartz S., Wagner L., Miller W. 2000; A greedy algorithm for aligning DNA sequences. J Comput Biol 7:203–214 [CrossRef]
     [Google Scholar]
  63. Zoetendal E. G., von Wright A., Vilpponen-Salmela T., Ben Amor K., Akkermans A. D., de Vos W. M. 2002; Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68:3401–3407 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.022848-0
Loading
Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome
J. Med. Microbiol. 60, 236 (2011); https://doi.org/10.1099/jmm.0.022848-0
/content/journal/jmm/10.1099/jmm.0.022848-0
/content/journal/jmm/10.1099/jmm.0.022848-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error